OTC, Supplement Sales Grow With Positioning To Ease Chronic Conditions
This article was originally published in The Pink Sheet Daily
Consumer health product sales climb as aging consumers turn more to OTCs and supplements to manage or prevent chronic conditions. Other factors include consumers’ desire for natural products, food-like platforms and customizable packaging, Euromonitor analysts say.
You may also be interested in...
CDER recommends the OTC industry ensure product innovations comply with monographs or have FDA approval prior to marketing. Umbrella-branding and facility registration rank high for the drug center in 2013.
J&J reports worldwide consumer sales dipped 0.6% to $3.6 billion despite retailers buying more upper respiratory and analgesic products to prepare for the cough and cold season. But in key OTC categories the firm is regaining market share it lost when its iconic brands were temporarily not available.
GlaxoSmithKline restructures its management to ensure adequate focus on its three core areas, pharmaceutical, vaccine and consumer. Consumer product sales fell 3% to $1.72 billion in the third quarter due to continuing supply interruptions and generally weaker markets.